Secular trend in universal hepatocellular carcinoma prevention: Taiwan, Poland, and Belgium experience

Table 1 Demographical distribution of hepatocellular carcinoma incidences and age-standardized incidence rates (with age-truncated population ≥ 30 years and ≤ 89 years) of hepatocellular carcinoma in Taiwan, Poland, and Flanders, 2000-2019

Country/region		HCC case number	Population (≥ 30 years and ≤ 89 years) in 1000		ASIR of HCC (≥ 30 years and ≤ 89 years) per 100000
			2000	2019	2000-2004	2005-2009	2010-2014	2015-2019
Taiwan	Male	153427	11390	11705	55.17	55.20	50.42	43.42
	Female	65370	10113	11897	21.91	21.95	19.89	16.20
Poland	Male	16696	18537	18373	3.21	2.89	2.91	2.77
	Female	13126	19716	19584	1.95	1.60	1.42	1.32
Flanders	Male	4689	3050	3294	2.66	3.76	5.03	5.63
	Female	2237	3081	3295	1.40	1.57	1.92	2.20

ASIR: Age-standardized incidence rate; HCC: Hepatocellular carcinoma.